Brief ReportsEffect of Simvastatin on Ischemic Signs and Symptoms in the Scandinavian Simvastatin Survival Study (4S)☆
References (14)
- et al.
The effect of probucol on femoral atherosclerosisthe Probucol Quantitative Regression Swedish Trial (PQRST)
Am J Cardiol
(1994) - et al.
Effects of colestipol-niacin therapy on human femoral atherosclerosis
Circulation
(1991) - et al.
Effect of partial ileal bypass on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia—report of the Program on the Surgical Control of Hyperlipidemias (POSCH)
N Engl J Med
(1990) Randomized trial of cholesterol lowering in 4444 patients with coronary heart diseasethe Scandinavian Simvastatin Survival Study (4S)
Lancet
(1994)The Lipid Research Clinics Coronary Primary Prevention Trial Results
JAMA
(1984)- et al.
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
N Engl J Med
(1996) - et al.
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
Circulation
(1994)
There are more references available in the full text version of this article.
Cited by (455)
The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study)
2023, Cardiovascular Revascularization MedicinePeripheral Artery Disease: Overview of Diagnosis and Medical Therapy
2023, Medical Clinics of North America2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke
2022, Journal of the Formosan Medical AssociationA comprehensive review on antithrombotic therapy for peripheral artery disease
2022, Seminars in Vascular Surgery
- ☆
This study was supported by a grant from Merck Research Laboratories, Rahway, New Jersey.
Copyright © 1998 Elsevier Science Inc. All rights reserved.